GLP-1 drugs can help lower the amount of insulin a person requires to control their blood sugar and may help people who have type 1 and obesity to lose weight
Commercial insurance coverage for GLP-1 weight-loss medications has expanded in 2024-2026 - many large employers added coverage - but coverage remains uneven and typically requires prior authorization for obesity indications
Dimitriadis, Sarah Zimner-Rapuch, Erin Johansson: Employees and shareholders of Eli Lilly and Company
However, as with any medication, there are concerns about its potential impact on other aspects of health, including the menstrual cycle
After reviewing your full health history, including any relevant medical conditions such as a personal or family history of thyroid C-cell tumors, and performing an individual assessment of your starting weight and aesthetic goals, your healthcare provider will determine whether participation is clinically appropriate